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OBJECTIVES This prospective study tested whether transmitral flow patterns add incremental value to peak
oxygen consumption (V˙O2) in determining the prognosis of patients with chronic congestive
heart failure (CHF) and systolic dysfunction.
BACKGROUND Peak V˙O2 is an objective marker of functional capacity and is routinely used as a criterion to
identify heart transplant candidates. Diastolic dysfunction limits functional capacity, but its
prognostic importance relative to that of peak V˙O2 is unknown.
METHODS Peak V˙O2 and mitral inflow velocities were prospectively measured in 311 consecutive patients
(mean age 54 years, 84% male) with impaired left ventricular function (ejection fraction
,40%; 88 patients with ischemic and 223 with dilated cardiomyopathy) who were evaluated
for heart transplant candidacy.
RESULTS During a mean follow-up period of 512 6 314 days, 65 patients died and 43 patients
underwent heart transplantation. Diastolic filling patterns, peak V˙O2 and left ventricular
end-diastolic diameters were independent predictors of cardiac mortality. In patients with
peak V˙O2 #14 ml/min per kg body weight, the outcome was markedly poorer in the presence
of restrictive filling patterns as compared with their absence (two-year survival rate 52% vs.
80%). Similarly, despite peak V˙O2 levels .14 ml/min per kg, the outcome was less favorable
in the presence of restrictive filling patterns (two-year survival rate 80% vs. 94%). A
risk-stratification model based on the identified independent noninvasive predictors separated
groups into those with high (93%), intermediate (65%) and low (39%) two-year survival rates.
CONCLUSIONS Transmitral flow patterns add incremental value to peak V˙O2 in determining the prognosis of
patients with CHF and impaired systolic function. (J Am Coll Cardiol 2001;37:1049 –55)
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Despite advances in the medical management of patients
with chronic congestive heart failure (CHF), the mortality
rate for this condition remains high, and heart transplanta-
tion is an important treatment option (1,2). Although a
large number of patients on the waiting list die before
transplantation, a significant proportion of listed patients
remain in a compensated clinical condition (3,4). Because
supply of donor organs does not meet clinical demands, risk
stratification in individual patients is an important clinical
task to guide patient management.
The New York Heart Association classification, the
presence of malignant ventricular arrhythmias, neurohor-
monal derangements and impaired functional status, as
assessed by cardiopulmonary exercise testing, have been pro-
posed as important prognostic markers in patients with CHF
(5–8). Of these factors, peak oxygen consumption (V˙O2) has
evolved as the most widely used clinical selection criterion to
direct patients toward heart transplantation (1,8).
There is increasing evidence that abnormalities of left
ventricular diastolic filling are intimately related to func-
tional status and prognosis of patients with chronic CHF
(9–11). Transmitral flow patterns characterized by short
isovolumetric relaxation times and dominant early diastolic
inflow velocities have been found in the presence of severely
impaired left ventricular compliance and elevated end-
diastolic filling pressures (12,13). This “restrictive” pattern
of mitral inflow has been recognized as a strong predictor of
mortality in advanced heart failure (10). Although diastolic
dysfunction is known to reduce exercise capacity, its prog-
nostic importance relative to that of peak V˙O2 and left
ventricular ejection fraction (LVEF) is unknown. There-
fore, the purpose of this prospective study was to investigate
whether mitral inflow patterns provide prognostic informa-
tion incremental to that obtained from routine cardiopul-
monary exercise testing in patients with impaired systolic
function (ejection fraction ,40%). A risk-stratification model
was developed based on noninvasive independent predictors
identified by the Cox proportional hazards model.
METHODS
Study group. The study group consisted of 311 consecutive
patients (mean age 54 years, 84% male) with chronic CHF
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(88 with ischemic and 223 with dilated cardiomyopathy)
who were evaluated for heart transplant candidacy. Patients
were prospectively included if they fulfilled the following
criteria: age 18 to 65 years, LVEF ,40% by radionuclide
angiography, previous symptoms of CHF, clinically stable
condition after conventional drug therapy for at least two
months and the ability to perform a symptom-limited stress
test. Patients were excluded in the presence of hypertrophic
cardiomyopathy, acute myocarditis, valvular and congenital
heart disease, severe pulmonary disease, potential for coro-
nary revascularization, unstable angina pectoris and malig-
nancy. Patients with more than mild mitral regurgitation, as
assessed by color Doppler echocardiography, were excluded
to avoid confounding mitral inflow variables. The study
protocol was approved by the institutional Ethics Commit-
tee, and patients gave their written, informed consent before
participating in the study.
Baseline evaluation and follow-up. At the time of entry
into the study, the patients’ past and current medical history,
current medications, symptoms and physical examination
findings were recorded. Baseline variables included New
York Heart Association functional class, routine blood
chemistry, chest X-ray and 12-lead electrocardiogram
(ECG). Patients were scheduled for regular clinical
follow-up evaluations every six months in the ambulatory
care center. Follow-up information was also obtained by
interviewing patients or their physicians, when applicable.
Two-dimensional echocardiography. Transthoracic
echocardiograms were obtained by using a commercially
available sector scanner (Aloka SSD 2200, Aloka Deubch-
land GmbH, Duesseldorf, Germany) with a 2.5-MHz
transducer. Two-dimensional echocardiograms and Dopp-
ler tracings of mitral inflow were recorded on videotapes and
analyzed off-line by an independent observer using a com-
puterized workstation (EchoCom Systems 2.4, Fulda, Ger-
many). Left atrial size, left ventricular end-diastolic diam-
eter (LVEDD) and left ventricular end-systolic dimensions
were measured from M-mode tracings of parasternal long-
and short-axis views. Left ventricular ejection fraction was
derived from apical two- and four-chamber views according
to the modified Simpson rule (14). All measurements were
performed in triplicate and averaged.
Doppler echocardiography. Transmitral flow velocity
tracings were obtained by pulsed wave Doppler echocardio-
graphy from apical four-chamber views, with the Doppler
sample volume positioned at the tips of the mitral leaflets
where color flow indicated maximal flow. From mitral
inflow patterns, we derived peak early (E) and late (A)
diastolic flow velocities, their E/A ratio and deceleration
time (DT) of early inflow, defined as the slope from peak E
extrapolated to the baseline value. The mean values were
obtained by averaging at least three consecutive beats.
Patients in sinus rhythm were assigned to two groups
according to the presence of restrictive and nonrestrictive
diastolic filling patterns. Restrictive mitral inflow patterns
were defined as an E/A ratio .2 or 1 to 2, but DT #140 ms
(15). Accordingly, nonrestrictive filling patterns were char-
acterized by an E/A ratio of either ,1 or 1 to 2, with DT
.140 ms.
In addition, the prognostic value of the presence of atrial
fibrillation was estimated by calculating relative risk ratios
that indicated the odds of dying for patients with restrictive
and those with nonrestrictive filling patterns. This approach
was chosen because patients in sinus rhythm comprised both
groups with restrictive and nonrestrictive filling patterns.
Cardiac catheterization. Routine left and right heart cath-
eterization, including selective coronary angiography, was
performed from the standard femoral approach in all pa-
tients. Measurements of pulmonary artery and intracardiac
pressures were performed using fluid-filled catheters connected
to standard Statham transducers (Statham P23ID). Cardiac
output was calculated according to the Fick principle.
Radionuclide angiography. Radionuclide left ventricular
angiograms were obtained using standard equilibrium
ECG-gated techniques, as previously reported (16). In
brief, red blood cells were labeled in vivo by an antecubital
intravenous injection of an unlabeled mixture of 4 mg
stannous fluoride and 6.8 mg sodium medronate, followed
by 20 to 25 mCi of technetium-99m 15 to 20 min later. The
counts of the precordial area were collected by a small
field-of-view Anger gamma camera (Siemens Orbiter ZLC
7500) equipped with a general-purpose, parallel-hole colli-
mator oriented in a 45° or “best septal” left anterior oblique
view. Global LVEFs were calculated from the raw time–
activity curves after background subtraction, using a com-
mercial computer system.
Cardiopulmonary exercise testing. Symptom-limited ex-
ercise testing with respiratory gas exchange analysis was
performed on a bicycle ergometer (Oxycon alpha, Jaeger,
Germany) at a constant pedaling speed of 60 rpm, with
work load increments of 15 W/min, as recently described
(16), after excluding significant pulmonary disease by using
pulmonary function tests.
Statistical analysis. Cardiac death was used as the clinical
outcome event. Descriptive data are expressed as the mean
value 6 SD. The distributions of continuous variables were
assessed for normality. The Student t test, with assumption
of unequal variance (normal distribution of variables), and
the Wilcoxon rank-sum test (non-normal distribution of
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variables) were used for group-to-group comparisons of
continuous variables.
Survival was analyzed by the Kaplan-Meier method, and
survival curves were compared by the log-rank test. Univar-
iate analysis was performed by using log-rank tests to
identify significant prognostic variables. The Cox propor-
tional hazards model was used for multivariate survival
analysis to determine independent predictors. A stepwise
selection procedure using the maximal partial likelihood
ratio chi-square test to enter (p , 0.1) or to remove (p .
0.1) a covariate into the model was employed. The variables
of prognostic importance, identified by the Cox procedure,
were used to derive a prognostic index to classify the
patients into different risk groups. A p value ,0.05 was
considered statistically significant.
RESULTS
Baseline characteristics of the study group. The final
study group consisted of 311 patients (84% men, mean age
54 6 10 years). A total of 48 (13%) of 359 initially screened
patients were excluded because they did not meet the entry
criteria.
Baseline data are summarized for all patients as a group and
separately for survivors and nonsurvivors (Table 1). During a
mean follow-up period of 512 6 314 days (range 15 to 1,509),
65 patients (21%) died and 43 (14%) underwent heart trans-
plantation because of end-stage heart failure.
Drug therapy, except for digoxin and warfarin, was similar in
both groups (Table 1). Compared with event-free survivors,
those who died were more symptomatic and had lower blood
pressures, lower LVEFs, larger LVEDDs, larger left atrial
dimensions, higher E/A ratios and shorter DTs, on average.
Independent predictors of survival. On multivariate anal-
ysis (Table 2), restrictive filling patterns (odds ratio [OR]
2.4, chi-square 7.2, p 5 0.007), peak V˙O2 #14ml/min per kg
(OR 3.2, chi-square 11.7, p 5 0.0006) and LVEDD .65 mm
(OR 3.2, chi-square 12.9, p 5 0.0003) were independent
predictors of cardiac mortality. Patients with atrial fibrillation
(n 5 46) had a 2.5-fold higher mortality risk than patients with
nonrestrictive filling patterns, but a similar risk as patients with
restrictive filling patterns (Table 2).
Table 1. Characteristics of Survivors and Nonsurvivors
Total
(n 5 311)
Survivors
(n 5 246)
Nonsurvivors
(n 5 65)
p
Value
Basic
Height (cm) 173 6 10 173 6 8 171 6 17 0.1449
Weight (kg) 79 6 15 79 6 14 80 6 19 0.5355
Age (yrs) 54 6 10 54 6 10 56 6 10 0.0317
NYHA functional class 2.4 6 0.7 2.3 6 0.7 2.6 6 0.7 0.0093
Excercise test
Peak V˙O2 (ml/min per kg) 14.7 6 5.5 15.4 6 5.7 12.0 6 3.7 , 0.0001
Heart rate at rest (beats/min) 82 6 17 80 6 17 87 6 16 0.0045
SBP at rest (mm Hg) 117 6 20 119 6 20 111 6 16 0.0035
Hemodynamic data
Mean PA pressure (mm Hg) 25 6 10 24 6 10 29 6 10 0.0011
PA resistance (dynezs21zcm25) 189 6 108 179 6 108 235 6 96 0.0034
LVEDP (mm Hg) 17 6 8 17 6 8 20 6 9 0.0481
Cardiac index (liter/min per m2) 2.1 6 0.6 2.1 6 0.6 1.9 6 0.5 0.0192
RNA
LVEF at rest (%) 22 6 10 24 6 11 17 6 8 , 0.0001
Echocardiography
Left atrium (mm) 46 6 8 46 6 7 48 6 8 0.0309
LVEDD (mm) 67 6 10 66 6 10 74 6 10 , 0.0001
LVEF (%) 24 6 12 25 6 13 19 6 10 0.0061
E/A ratio 1.9 6 1.6 1.7 6 1.5 2.7 6 2.1 , 0.0001
DT-E (ms) 173 6 68 180 6 66 137 6 65 , 0.0001
Restrictive filling pattern (%) 50 43 75 , 0.0001
Medications (%)
ACE inhibitors 89 87 92 0.2866
Diuretics 79 78 86 0.1532
Digoxin 64 48 75 0.0384
Beta-blockers 26 27 18 0.1238
Nitrates 21 20 23 0.6226
Warfarin 67 64 80 0.0177
Antiarrhythmics 12 13 9 0.3904
*Survivors versus nonsurvivors. Data are presented as the mean value 6 SD or percentage of patients.
ACE 5 angiotensin-converting enzyme; DT-E 5 E wave deceleration time; E/A 5 ratio of early transmitral flow velocity
to atrial flow velocity; LVEDD 5 left ventricular end-diastolic diameter; LVEDP 5 left ventricular end-diastolic pressure;
LVEF 5 left ventricular ejection fraction; NYHA 5 New York Heart Association; PA 5 pulmonary artery; RNA 5
radionuclide angiography; SBP 5 systolic blood pressure; V˙O2 5 oxygen consumption.
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Survival was significantly lower in patients with peak V˙O2
#14 ml/min per kg than in patients with peak V˙O2
.14 ml/min per kg, with a one-year survival rate of 76%
versus 93% and a two-year survival rate of 59% versus 90%,
respectively.
Prognostic value of Doppler echocardiographic transmi-
tral flow patterns. In patients with a restrictive filling
pattern, peak V˙O2 was lower (13.2 6 4.2 ml/min per kg,
n 5 122) than in those without a restrictive filling pattern
(16.6 6 5.8 ml/min per kg, n 5 143, p , 0.0001). In
patients with peak V˙O2 #14 ml/min per kg, the presence of
a restrictive filling pattern indicated a very poor prognosis
(two-year survival rate 52% vs. 80% in those with a
nonrestrictive filling pattern) (Fig. 1). Likewise, in those
patients with peak V˙O2 .14 ml/min per kg, a restrictive
filling pattern indicated less favorable survival than that in
patients without a restrictive pattern (two-year survival rate
80% vs. 94%) (Fig. 1).
As a group, patients with restrictive filling patterns were
more symptomatic and had more extensive left ventricular
dilation and a lower LVEF as compared with patients
without restrictive filling patterns (Table 3). The frequen-
cies of cardiac deaths and heart transplantations in relation
to categoric grouping of patients according to their mitral
filling pattern and peak V˙O2 are shown in Table 4.
Construction of a noninvasive risk score. To better de-
fine cardiac risk for individual patients in clinical practice, a
noninvasive predictive model was developed based on the
independent risk factors identified by multivariate analysis:
peak V˙O2 #14 ml/min per kg, atrial fibrillation, restrictive
mitral inflow patterns and LVEDD .65 mm. Low, me-
dium and high risk groups were identified by the presence of
#1, 2 or 3 risk factors with survival rates at two years of
93%, 65% and 39%, respectively (Fig. 2).
DISCUSSION
The results of this study show that Doppler mitral inflow
patterns provide prognostic information that is incremental
to cardiopulmonary exercise testing in patients with chronic
CHF who were evaluated for heart transplantation. The
importance of diastolic dysfunction as a prognostic marker
has been previously reported (10,15,17,18). However, clin-
ical routine practice usually includes cardiopulmonary exer-
cise testing to evaluate functional status in patients with
chronic CHF. To the best of our knowledge, this is the first
study to demonstrate that interrogation of transmitral flow
provides prognostic information that is independent of peak
V˙O2 in patients with chronic CHF and impaired systolic
function. An increase in chamber stiffness due to extensive
scarring and structural changes of myocardial tissue, accom-
panied by an increase in left ventricular filling pressures and
left atrial pressures, is the most likely underlying mechanism
of this redistribution of flow to early diastole (19).
Risk stratification in chronic CHF by using noninvasive
models. Identification of individual patients who benefit
the most from heart transplantation is a great clinical
challenge. The level of LVEF alone is insufficient to predict
an unfavorable outcome. Patients with the same levels of
Table 2. Predictors of Survival: Multivariate Analysis
Variable Chi-Square
Relative Risk
(95% CI) p Value
Restrictive filling 7.3 2.4 (1.3–4.5) 0.007
AF vs. non-RFP 5.2 2.5 (1.1–5.6) 0.02
AF vs. RFP 0.02 1.0 (0.5–2.0) 0.86
Peak V˙O2 #14 ml/min per kg 11.7 3.2 (1.6–5.9) 0.0006
LVEDD .65 mm 12.9 3.2 (1.7–6.1) 0.0003
AF 5 atrial fibrillation; CI 5 confidence interval; RFP 5 restrictive filling pattern; other abbreviations as in Table 1.
Figure 1. Mitral inflow patterns provide prognostic information incremen-
tal to that of peak V˙O2. The outcome was significantly poorer in the
presence of restrictive filling patterns than in their absence, both in patients
with peak V˙O2 #14 ml/min per kg (upper panel) and in patients with peak
V˙O2 .14 ml/min per kg (lower panel).
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reduced ejection fractions may have a markedly different
clinical course, contributing to the uncertainty in judging
the prognosis of an individual patient (6). Peak V˙O2 is the
only prognostic factor that is widely used in routine clinical
practice as a selection criterion in patients with CHF (1).
Levels of peak V˙O2 #14 ml/kg per min are usually consid-
ered to indicate the need for heart transplantation. How-
ever, a single cut-off value appears unlikely to unequivocally
predict the need for transplantation and neglects other
routinely obtained prognostic factors, such as clinical signs
and symptoms of heart failure or the presence of malignant
ventricular arrhythmias (5–7). The present study shows that
although restrictive filling patterns have prognostic value,
there is substantial overlap of filling indexes between survi-
vors and nonsurvivors. Thus, for the patient groups as a
whole, Doppler-derived information on diastolic function
may have important prognostic information, but may not be
applicable to an individual patient.
Therefore, there is a clear need for noninvasive predictive
models to better define individual risk. Several studies have
shown that a combination of predictive factors more accu-
rately predict survival, but involved either small patient
groups or neglected peak V˙O2 or did not evaluate diastolic
function (20–22). Notably, the models including invasive
variables did not perform better than the noninvasive
models (21).
In the present study, a predictive model was constructed
on the basis of independent risk factors identified by
multivariate analysis (peak V˙O2 #14 ml/min per kg, restric-
tive mitral inflow pattern, atrial fibrillation and LVEDD).
A combination of these predictive variables increased diag-
nostic accuracy. Low, medium and high risk groups were
defined by the presence of #1, 2 or 3 risk factors, with
two-year survival rates of 93%, 65% and 39%, respectively.
The predictive power of this model was clearly superior to
that of peak V˙O2 alone and compared favorably with the
results of previous investigations (20–22). The major ad-
vantage of this risk-stratification model is that the prognos-
tic noninvasive variables evaluated in this study are readily
available in routine clinical practice and are cost-effective,
giving access to repeat evaluations of cardiac status and
function in the clinical setting. However, it should be
considered that the risk score proposed in this study needs
to be tested in a prospective study of an independent patient
population.
Study limitations. Several potential limitations should be
considered when interpreting the results of this study. We
investigated patients with chronic CHF due to either
ischemic or nonischemic dilated cardiomyopathy and a
mean LVEF of 22%. Thus, the results cannot be general-
ized to other patients with impaired diastolic function and
less compromised or even preserved left ventricular systolic
function.
The model is further complicated by its static nature; it
uses only variables obtained at the time of initial enrollment
after medical therapy for at least eight weeks and does not
account for potential later changes in cardiac status.
Furthermore, survival analysis was limited to data rou-
tinely collected during the study period. Other potentially
important predictors of survival, such as serologic markers,
were not considered because of their currently limited
availability as routine clinical variables.
Table 3. Patient Characteristics According to Their Transmitral Filling Patterns
Non-RFP
(n 5 143)
RFP
(n 5 122)
p
Value*
NYHA functional class 2.1 6 0.7 2.6 6 0.7 , 0.0001
HR at rest (beats/min) 80 6 18 83 6 15 0.07
SBP at rest (mm Hg) 122 6 18 112 6 15 , 0.0001
Peak V˙O2 (ml/min per kg) 16.6 6 5.8 13.2 6 4.2 ,0.0001
PA resistance (dynezs21zcm25) 164 6 93 205 6 99 0.007
LVEDP (mm Hg) 15 6 8 21 6 8 , 0.0001
RNA LVEF (%) 26 6 12 19 6 9 , 0.0001
LVEDD (mm) 66 6 11 70 6 10 0.01
Echocardiographic LVEF (%) 27 6 12 20 6 10 , 0.0001
*p , 0.05 was considered significant. Data are expressed as the mean value 6 SD.
HR 5 heart rate; RFP 5 restrictive filling pattern; other abbreviations as in table 1.
Table 4. Frequency of Death and Heart Transplantation in Relation to Mitral Inflow Patterns
and Maximal Oxygen Uptake
RFP Non-RFP
Peak V˙O2
<14 ml/min
per kg
Peak V˙O2
>14 ml/min
per kg
Peak V˙O2
<14 ml/min
per kg
Peak V˙O2
>14 ml/min
per kg
Total 79 43 61 82
Deaths 31 7 10 4
HTX 19 6 7 5
Data are presented as the number of patients.
HTX 5 heart transplantation; RFP 5 restrictive filling pattern; V˙O2 5 oxygen consumption.
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Another limitation is that mitral inflow patterns may not
necessarily reflect left ventricular diastolic dysfunction. Di-
astolic filling patterns can be influenced by age, heart rate
and loading conditions (23,24). Age is unlikely to have
significantly influenced our results, because it could not be
shown to have prognostic value for survival. Heart rate was
significantly higher in nonsurvivors than in survivors, po-
tentially leading to overestimation of late diastolic velocities,
and thus supporting our results even more. The loading
conditions of patients were not characterized in this study,
but might have been influenced by the patients’ medica-
tions. However, diuretic agents and angiotensin-converting
enzyme inhibitors were equally distributed among the
groups.
Interpretation of transmitral flow patterns may also be
confounded by factors, such as pericardial restraint, left
atrial pressure and compliance, right and left ventricular
interplay, coronary turgor and intrinsic properties of left
atrial and left ventricular muscle (25). It must also be kept in
mind that flow velocity-derived indexes of diastolic filling
are only indirect measures of diastolic function and do not
directly assess ventricular relaxation and compliance and are
subject to interobserver and intraobserver variations (26).
Clinical implications. The present study clearly shows
that restrictive filling patterns indicating diastolic dysfunc-
tion provide prognostic value that is incremental to that
derived from cardiopulmonary exercise testing. Implemen-
tation of Doppler filling patterns can add important infor-
mation to the process of clinical decision making on the
basis of peak V˙O2. Although the proposed risk-stratification
model based on the data of this study needs to be prospec-
tively validated in a separate patient group, the patients
presenting with a combination of identified risk factors are
more likely to benefit most from early heart transplantation.
This predictive model carries the potential to facilitate
identification of high risk patients in routine clinical practice
and offers the specific advantage of allowing repetitive
evaluations when an update of the patient’s status is war-
ranted. However, one should also consider that any such
predictions should be integrated with other clinical impres-
sions and not to make critical decisions based on computa-
tional models alone. A potential future advantage of using
Doppler echocardiography to identify diastolic dysfunction
in patients with CHF may be to identify patients amenable
to new pharmacologic approaches, such as the use of nitric
oxide donors or drugs that enhance nitric oxide release (27).
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